Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 pharmacokinetics study of PF-07976016 in healthy adults
NL-OMON58678Phase 1Completed
- Sponsor
- Pfizer
- Start
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of PF-07976016, sponsored by Pfizer. Started May 2025; status: completed.
02
Drugs
PF-07976016
Beyond the preview
Go deeper on NL-OMON58678.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58678.